GU Cancer

Clinical highlights, expert viewpoints, and pivotal data from the ASCO genitourinary cancer sessions, showcasing emerging evidence and advancing therapeutic strategies.

GU Cancer

Experts Dr. Rahul Gosain, Dr. Rohit Gosain, Dr. Brian Rini, and Dr. Thomas Powles discuss 6 clinical trials on treatment options for genitourinary cancers.

GU Cancer

07/15/2026

6 Trials Impacting Treatment Options for Genitourinary Cancers

Thomas Powles, MD, MBBS, MRCPBrian Rini, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD

Dr. Brendan Guercio and Dr. Tian Zhang discuss perioperative strategies for high-risk localized prostate cancer at ASCO 2026.

GU Cancer

06/25/2026

Practice-Changing Updates for Prostate Cancer From ASCO 2026

Brendan Guercio, MDTian Zhang, MD, MHS

Dr. Michael Serzan and Dr. Sumanta Pal discuss adjuvant immunotherapy in renal cell carcinoma at OncUpdates, with a city skyline and Ferris wheel in the background.

GU Cancer

06/22/2026

Adjuvant Immunotherapy in RCC: Insights From RAMPART

Sumanta Pal, MD, FASCOMichael Serzan, MD

City street scene with theater marquee and skyscrapers, highlighting recent advances in GU cancers from ASCO 2026.

GU Cancer

06/19/2026

Practice-Changing Shifts in GU Cancers From ASCO 2026

Manas Pustake, MD

City skyline with water and text about GU experts on bladder, kidney, and prostate cancer trials.

GU Cancer

06/17/2026

GU Experts Weigh In on Trials That Could Redefine Bladder, Kidney, and Prostate Cancer Care

Andre Kydd, MD, PhD

Visual representation of integrating circulating tumor DNA (ctDNA) into muscle-invasive bladder cancer treatment strategies, with a city skyline background.

GU Cancer

06/14/2026

Integrating ctDNA Into Muscle-Invasive Bladder Cancer Treatment

Miles Hsu, MD

Dr. Elias Chandran and Dr. Andrea Apolo discuss the latest developments in bladder cancer care, highlighting EV-Pembrolizumab's role in redefining treatment strategies.

GU Cancer

06/06/2026

The Impact of EV Trials Across Bladder Cancer Populations

Andrea Apolo, MDElias Chandran, MBBS, FRACP

Clinical trial image showing Broke Kania, DO, discussing the Talaporo-3 study on cancer treatment with Talazoparib and Enzalutamide for HRR-mutated mCSPC.

GU Cancer

06/06/2026

TALAPRO-3: A Major rPFS Win in HRR-Mutated mCSPC, But Which Patients Benefit Most?

Brooke Kania, DO

Overview of EV-302 update on enfortumab vedotin and pembrolizumab improving survival in metastatic urothelial cancer patients.

GU Cancer

06/03/2026

EV-302 Update: Enfortumab Vedotin Plus Pembrolizumab Maintains Survival Benefit at 3.5 Years in Metastatic Urothelial Cancer

Saad Atiq, MD

GU Malignancy Recap from 2025 ASCO, oncology, cancer research, medical conference, Dr. Tian Zhang, Dr. Rohit Gosain, Dr. Rahul Gosain, oncotherapy, cancer treatment advances, oncology news, clinical updates, oncologists, cancer management.

GU Cancer

07/22/2025

GU Malignancy Recap from 2025 ASCO

Tian Zhang, MD, MHS

OncUpdates conference panel discussion featuring medical professionals discussing oncology advancements and cancer treatment strategies at a professional medical event.

GU Cancer

07/02/2025

Breakthroughs in Bladder, Prostate, and Kidney Cancer: What Oncologists Need to Know From ASCO 2025

Saad Atiq, MD

Microcancer cells in human bladder illustrating cancer biology and urology research.

GU Cancer

06/30/2025

Durvalumab Enters the Perioperative Landscape in Muscle-Invasive Bladder Cancer: Reflections from the NIAGARA Trial and ASCO 2025 Updates

Charbel Matar, MD

High-tech illustration of a human prostate gland with medical visualization elements, symbolizing advanced prostate cancer research and treatment options.

GU Cancer

06/11/2025

New Questions in Muscle-Invasive Bladder Cancer After the NIAGARA Trial

Albert Jang, MDMichael Serzan, MD

Advances in oncology research and treatment discussed at OncUpdates, featuring medical professionals sharing insights on cancer therapies and breakthroughs, highlighting the latest in cancer care.

GU Cancer

06/11/2025

Highlights From the AMPLITUDE Study at ASCO 2025

Albert Jang, MDMichael Serzan, MD

Alcohol-reinforcement-removal-urinary-kidney-cancer-treatment-therapy-illustration.

GU Cancer

06/11/2025

Updated CheckMate 214 Results Support Ipi-Nivo for Favorable-Risk Kidney Cancer

Albert Jang, MDMichael Serzan, MD

Bald man in suit and tie speaking into a microphone at a conference, sitting on a wicker armchair surrounded by plants and modern decor, representing oncology professional at a medical event.

GU Cancer

06/10/2025

Second-Line Treatment Sequencing in Metastatic RCC

Enrique Grande, MD, PhD, MSCKaran Jatwani, MD

Answer:.

GU Cancer

06/10/2025

NIAGARA Trial: A New Standard of Care in MIBC

Petros Grivas, MD, PhDMichael Serzan, MD

Cutting-edge oncology conference interview with medical professionals discussing advancements in cancer research and treatment strategies for improved patient outcomes.

GU Cancer

06/10/2025

The Future of Sacituzumab Govitecan in Metastatic Urothelial Cancer

Michael Serzan, MDPetros Grivas, MD, PhD